SKI Market

Indian Indices

Sensex

80,722.94 -1,546.84
( -1.88%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.92 0.08
(0.09%)

EUR-INR

109.97 0.03
(0.03%)

GBP-INR

126.94 0.27
(0.21%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indiamart Intermesh Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

542726

INE933S01016

373.1225766

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INDIAMART

19.3

13256.73

EPS(TTM)

Face Value()

Div & Yield %

114.32

2.26

Back

Welcure Drugs & Pharmaceuticals standalone net profit rises 361.96% in the September 2025 quarter

Nov 14,2025

Net profit of Welcure Drugs & Pharmaceuticals rose 361.96% to Rs 8.50 crore in the quarter ended September 2025 as against Rs 1.84 crore during the previous quarter ended September 2024. Sales rose 167.29% to Rs 65.62 crore in the quarter ended September 2025 as against Rs 24.55 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	65.62	24.55	167
OPM %	17.31	7.54	-
PBDT	11.36	1.85	514
PBT	11.36	1.84	517
NP	8.50	1.84	362

80,722.94 -1,546.84 ( -1.88%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.92 0.08 (0.09%)

109.97 0.03 (0.03%)

126.94 0.27 (0.21%)

0.60 0.00 (0.00%)